A low monthly figure is useful only if you know what obligation comes with it. LumiMeds advertises complete GLP-1 care starting at $89 a month, including medication, clinician care and shipping. It also promotes no membership fee and a price locked for life. Yet its membership terms describe fixed-term financial commitments, restrictions on cancellation and a right to change prices with advance notice. For someone comparing household expenses, the central issue is not simply whether $89 is affordable. It is whether that figure describes the actual plan being purchased.
This review examines LumiMeds’ product, marketing and contractual documents consulted October 19, 2026; that is the research date, not necessarily when those pages were updated. The documented business connects patients with independent medical professionals and outside pharmacies rather than directly providing medical or pharmacy services. Its offerings include compounded injectable semaglutide and tirzepatide, alongside NAD+ plans. The advertised prices deserve to be reported, not hidden behind uncertainty. But the unresolved differences between the sales pages and terms make a written, plan-specific quote especially important before payment.
At a glance
- Compounded semaglutide
- Advertised from $89 per month; the product page describes a subcutaneous multidose vial with syringe and monthly, three-, six- and 12-month options.
- Compounded tirzepatide
- Advertised at $125 per month as a flat rate available, with a subcutaneous multidose vial and syringe; totals for the different plan durations are not established.Sources: [5]
- Advertised inclusions
- The homepage includes medication, delivery and check-ins, with no membership fee or dose-increase surcharge.Sources: [3]
- Potential full-term obligation
- Membership terms allow payment upfront or in scheduled installments but say the entire contracted term remains payable.Sources: [2]
- Refund boundaries
- Terms restrict cancellation after pharmacy submission, exclude refunds for shipped medication and provide ten business days to process approved refunds.Sources: [6]
Start with the purchase amount, not the monthly label
LumiMeds’ semaglutide page advertises “$89/mo” with a “flat rate available”; its tirzepatide page uses the same framing at $125. Both list monthly, three-, six- and 12-month options. These are compounded products administered subcutaneously, presented as multidose vials with syringes and described as coming from a 503A pharmacy. The supplied pages do not assign a total purchase price, initial collection amount or payment schedule to each duration. A plan lasting several months does not, by itself, establish the quantity supplied or the minimum commitment attached to every advertised offer.
The homepage frames complete care as starting at $89 a month, displays a previous $189 price and separately promotes savings of $175 every month. The supplied material does not explain that savings calculation, so it should not become a budget assumption. Nor is there a documented introductory-to-renewal price schedule for each option. The practical next step is to request the exact first charge, subsequent charge dates and full contracted amount for the selected product. Our guide to understanding the first GLP-1 payment explains why those numbers can differ from a monthly headline.
| Offering or payment feature | What LumiMeds advertises | What remains to confirm |
|---|---|---|
| Compounded subcutaneous semaglutide, multidose vial and syringe | From $89/month; monthly, 3-, 6- and 12-month options | Selected-plan total, first collection and supply quantity |
| Compounded subcutaneous tirzepatide, multidose vial and syringe | $125/month flat rate available; monthly, 3-, 6- and 12-month options | Conditions qualifying for that rate and payment schedule |
| NAD+ plans | $133/month; price locked forever; no membership required | Commitment and presentation attached to that amount |
| Klarna | Option to split payment for any plan | Financing terms and effect on the underlying obligation |
| FSA/HSA funds | Advertised payment option; eligibility on selected plans | Whether the chosen plan qualifies |
The advertised bundle covers more than medication
LumiMeds says its price includes medication, delivery and check-ins, with no membership fee and no surcharge when a dose increases. Its catalog adds a one-to-one telehealth consultation, physician support, a prescription if appropriate and monthly remote check-ins. The homepage says treatment changes, refills and questions are part of the plan, with messaging to the provider. Taken as commercial promises, those are meaningful inclusions: the advertised figure is not presented merely as an access fee that leaves the medication price entirely separate.
The boundaries of that bundle still need confirmation. The supplied material does not establish mandatory laboratory requirements or whether any required testing would be included. It also does not resolve how the advertised absence of a membership fee fits the separate membership agreement. A useful written quote would identify every included clinical service, any separately charged service and the medication fulfillment arrangement. Our guide to what a GLP-1 program price includes provides a way to separate those categories without assuming that a broad care promise answers every billing question.
Installments may divide a commitment rather than shorten it
The membership terms identify the operator as Luminate Ventures LLC, doing business as LumiMeds, with a contact address at 1810 E Sahara Avenue, Suite 215, Las Vegas, Nevada 89104. Those terms say each membership requires a fixed-term financial commitment. Payment may be collected in full at enrollment or through scheduled installments, as specified at purchase. Crucially, the agreement says the entire term remains payable regardless of payment frequency. Upfront payment and installments are alternatives here; the documents do not establish mandatory prepayment for every plan.
That distinction matters when comparing a monthly-looking price with a genuinely month-to-month arrangement. LumiMeds also advertises Klarna and use of FSA/HSA funds, while noting FSA/HSA eligibility on selected plans. The supplied evidence does not establish financing terms or which purchases qualify. The catalog says no insurance is required; membership terms say the arrangement is not insurance, LumiMeds does not submit insurance claims and third-party reimbursement is not guaranteed. These are separate questions: how a purchase is financed, whether an account can fund it and whether an insurer will reimburse it.
A lifetime-price promise needs a plan-specific explanation
The homepage’s “Price locked for life” language is unusually strong. It appears alongside the starting price and the promise of medication, clinician care and free shipping. Yet the membership terms reserve the right to modify membership pricing at LumiMeds’ discretion with at least 28 days’ notice. The documents supplied do not explain whether the marketing promise applies to a different product, overrides that clause or carries conditions not shown. It would be inappropriate to choose one statement as controlling without seeing the agreement attached to the actual purchase.
Renewal is another unresolved part of the budget. The supplied sources do not explain automatic renewal, renewal notices or how to prevent a subsequent contractual period. The 28-day price-change notice is not a documented cancellation deadline and should not be treated as one. Ask whether the chosen plan renews, what amount would be charged and what action stops the next term. Our guide to introductory offers and renewal prices is useful here, although LumiMeds’ evidence does not establish that its advertised rate is necessarily an introductory-only price.
Cancellation and refunds have several different boundaries
LumiMeds’ homepage says patients receive a full refund if their provider decides treatment is not appropriate. The membership terms, however, call membership plans noncancelable and nonrefundable during the contracted term, including after a health change, relocation or dissatisfaction. Outstanding installments remain due. Another clause in that same agreement allows a $100 nonrefundable cancellation fee to be deducted from any applicable refund for reasons other than prescription denial, reserving full refunds for denial. These provisions do not form a single clear cancellation policy for every advertised plan.
The terms of use add fulfillment-based restrictions: orders cannot be canceled once submitted to the pharmacy, and LumiMeds determines whether processing, filling or shipping has begun. Shipped medications are not refundable. Completed medical consultations have nonrefundable fees, and prescription products cannot be returned for reuse or resale. Approved refunds are processed within ten business days to the original payment method; that is not a guarantee of bank receipt within ten days. Before paying, ask which rule governs a denial, voluntary withdrawal and an order already sent to the pharmacy. The cancellation and refund guide helps distinguish stopping service from recovering money.
The care pathway involves independent decision-makers
LumiMeds describes itself as a patient-management platform working with independent physicians and practitioners, not as the direct medical or pharmacy provider. Payment does not guarantee a prescription or dispensing. The terms name Telegra MD LLC among possible affiliated professional entities and allow real-time audio-video consultations and asynchronous communication when appropriate. The homepage describes an initial health-history and goals questionnaire taking about two minutes. That is an advertised intake duration, not a documented turnaround time for clinical review, prescribing or receipt of medication.
The company says final medication details and fulfillment are confirmed by the licensed provider after intake. Administrative eligibility requires being at least 18 or legally emancipated, living in a participating U.S. state and maintaining an account in good standing. Availability is limited to certain states, with no complete list supplied. The site identifies Dr. Teresa Walsh as medical director and claims obesity-medicine certification and licensure in all 50 states; those claims were not independently verified and do not establish nationwide service availability. Neither the intake nor payment replaces a clinician’s decision.
Included shipping does not resolve delivery risk
The dispensing pharmacy is independent, and LumiMeds reserves pharmacy selection. Patients may make special requests but do not have a contractual right to dictate a particular pharmacy. The supplied sources do not identify the actual dispensing pharmacies by name. Product materials advertise cold-chain, temperature-controlled delivery included in the monthly cost. The terms instead leave cooling materials to the dispensing pharmacy and say their inclusion does not imply a specific transit-temperature requirement, even when refrigeration appears on the medication label. That is a material difference between the delivery promise and the contractual language.
The terms also transfer risk of loss when the package reaches the carrier, make replacement shipments discretionary and disclaim responsibility for incorrect addresses. Shipping errors, damage or billing discrepancies must be reported within 48 hours after package receipt, with the order number, tracking information, lot number and relevant photographs. No concrete review, preparation, transit or arrival timeline is established. Separately, FDA advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. Free delivery therefore does not settle either replacement costs or the handling of a concerning shipment.
Judge ongoing value by access and documentation, not testimonials
Patients can send portal messages at any time, including questions, treatment updates and refill requests. Published response hours are Monday through Friday, 7 a.m.–7 p.m., and weekends, 8 a.m.–4 p.m., stated as PST. LumiMeds also lists (415) 968-0890. Around-the-clock message submission is not continuous clinical response, and no guaranteed reply time appears in the supplied evidence. The company discloses that testimonial participants were compensated and that results vary. Those accounts do not establish what care access or treatment results a new purchaser will receive.
LumiMeds acknowledges that its compounded medications require prescriptions and are not FDA approved. FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality, and recommends them when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not establish clinical inequivalence. Neither approved-drug research nor a higher price proves the performance of LumiMeds’ preparations. FDA has also received reports of compounded-medication measurement or administration errors; instructions should be clarified with the prescriber or pharmacist, not reconstructed from a review. Cost transparency and appropriate clinical follow-up remain separate requirements.
Questions & answers
Can I assume my first LumiMeds charge will be $89?
No. The homepage advertises care starting at $89 monthly, and the semaglutide page lists that rate with multiple plan durations. The supplied evidence does not establish the first collection for each option. Membership payments may be upfront or installments. Request the checkout amount, total obligation and dated payment schedule for the exact plan rather than treating the headline as a complete invoice.
Does LumiMeds charge more when the prescribed dose increases?
The homepage explicitly says there is no upcharge when a dose increases and includes medication, delivery and check-ins. That is a useful advertised condition. Obtain confirmation that it applies to your selected product and duration, especially because the documents do not establish every option’s total price or explain how the membership terms relate to the no-membership-fee offer.
What happens if LumiMeds’ clinician declines to prescribe?
The homepage promises a full refund when the provider determines treatment is inappropriate, and membership terms reserve full refunds for prescription denial. However, separate terms make completed consultation fees nonrefundable. Ask how those provisions apply together before paying. An approved refund is processed within ten business days under the terms of use; the documents do not guarantee when your bank will post it.
Can I use insurance, Klarna or FSA/HSA money?
LumiMeds says insurance is not required, does not submit insurance claims and does not guarantee reimbursement. It advertises Klarna installments and FSA/HSA payment, with account eligibility noted for selected plans. Confirm the chosen plan’s eligibility and financing conditions separately. Splitting payment should not be assumed to remove a full-term obligation described in the applicable membership agreement.
Can I choose the pharmacy or count on a replacement shipment?
The terms allow special pharmacy requests to be considered but reserve pharmacy selection to LumiMeds. They make replacement shipments for loss or damage discretionary rather than guaranteed. Report package problems within 48 hours of receipt and retain the requested identifying information. If an injectable GLP-1 shipment is warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or pharmacy.
Does LumiMeds sell anything besides its GLP-1 plans?
The homepage also advertises NAD+ plans at $133 per month, described as price locked forever with no membership required. The supplied homepage material does not establish the presentation or commitment associated with that amount. An active-patient referral offer mentions a $40 reward and $40 off products, but complete referral conditions are unavailable. Neither offer should be treated as a confirmed reduction in a GLP-1 bill.
Our assessment
LumiMeds documents an appealingly broad advertised bundle: compounded medication, clinical contact, monthly check-ins and delivery, with semaglutide starting at $89 monthly and tirzepatide advertised at $125. Its central weakness for budgeting is not a lack of visible prices but uncertainty about the obligations attached to them. Fixed-term payment terms, price-change rights and several refund restrictions sit alongside simpler marketing promises. Before purchasing, obtain a written plan total, first charge, installment schedule, renewal rule, applicable cancellation policy and shipment-resolution process. Clear answers could make the offer easier to compare; unresolved answers leave meaningful financial exposure. This documentary record supports examining LumiMeds as a GLP-1 platform, but not treating its headline price as a complete or independently verified account of the purchase.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.